Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy

PURPOSE: The significance of radiotherapy (RT) –associated cardiac injury for stage III non–small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with worse overall survival in the Radiation Therapy Oncology Group (RTOG) 0617 study. We assessed the impact of heart dose in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Wang, Kyle, Eblan, Michael J., Deal, Allison M., Lipner, Matthew, Zagar, Timothy M., Wang, Yue, Mavroidis, Panayiotis, Lee, Carrie B., Jensen, Brian C., Rosenman, Julian G., Socinski, Mark A., Stinchcombe, Thomas E., Marks, Lawrence B.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2017
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455462/
https://ncbi.nlm.nih.gov/pubmed/28113017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.0229
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky